[{"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-13027.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-2368181.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-197291.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":326156.0,"ProceedsFromWarrantExercises_1_Q1_USD":null,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q1_USD":574821.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":348495.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":298305.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q1_USD":246004.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q1_USD":253384.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q1_USD":255137.0,"OperatingLeaseExpense_1_Q1_USD":89684.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":1737611.0,"Goodwill_0_Q1_USD":11640000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":4977.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":2755034.0,"PrepaidExpenseCurrent_0_Q1_USD":99872.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":76834.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":76834.0,"NonoperatingIncomeExpense_1_Q1_USD":339393.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-2519365.0,"DepreciationDepletionAndAmortization_1_Q1_USD":30458.0,"StockIssuedDuringPeriodValueOther_1_Q1_USD":null,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0399,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1637878.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1461156.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":276456.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":154824000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q1_USD":null,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_1_Q1_USD":3424.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":11241.0,"EquityFairValueAdjustment_1_Q1_USD":-427400.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":5965661.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":2755034.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":326156.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":28389.0,"OtherReceivablesNetCurrent_0_Q1_USD":null,"DepositsAssetsNoncurrent_0_Q1_USD":137550.0,"OtherIndefiniteLivedIntangibleAssets_0_Q1_USD":166464000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_1_Q1_USD":-1982.0,"AccountsPayableTradeCurrent_0_Q1_USD":282376.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":316950.0,"InterestIncomeExpenseNet_1_Q1_USD":-92313.0,"IncreaseDecreaseInOperatingLiabilities_1_Q1_USD":-65452.0,"IncreaseDecreaseInOperatingAssets_1_Q1_USD":-65981.0,"LongTermNotesPayable_0_Q1_USD":4654765.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":77249.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":73978.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":931131.0,"InterestAndOtherIncome_1_Q1_USD":4306.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":null,"LiabilitiesCurrent_0_Q1_USD":832177.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":175133368.0,"Liabilities_0_Q1_USD":10903132.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-142994.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-310501.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-122794.0,"GrossProfit_1_Q1_USD":null,"GeneralAndAdministrativeExpense_1_Q1_USD":1777923.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":24965.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.05,"Depreciation_1_Q1_USD":26545.0,"CostOfRevenue_1_Q1_USD":null,"CommonStockValue_0_Q1_USD":4664.0,"CommonStockSharesOutstanding_0_Q1_shares":46636976.0,"CommonStockSharesIssued_0_Q1_shares":46636976.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-2730700.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":5965661.0,"AssetsNoncurrent_0_Q1_USD":168316262.0,"AssetsCurrent_0_Q1_USD":6065533.0,"Assets_0_Q1_USD":175133368.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4115883.0,"AdditionalPaidInCapital_0_Q1_USD":230823367.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":null,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q1_USD":-28389.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2755665.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":null,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":179558.0,"ShareBasedCompensation_1_Q1_USD":326156.0,"ResearchAndDevelopmentExpense_1_Q1_USD":1050376.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-2858757.0,"OperatingExpenses_1_Q1_USD":2858757.0,"InterestPaidNet_1_Q1_USD":42365.0,"IncomeTaxesPaidNet_1_Q1_USD":37.0,"DepreciationAndAmortization_1_Q1_USD":30458.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":1200000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":273345.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":46605118.0,"StockholdersEquity_0_Q1_USD":164230236.0,"Revenues_1_Q1_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-66584768.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":751573.0,"NetIncomeLoss_1_Q1_USD":-2396570.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q1_shares":4988.0,"Ticker":"ENOB","CIK":"1527728","name":"ENOCHIAN BIOSCIENCES INC","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]